EcoDrugPlus

Opioid Receptor Kappa 1

Ensembl ID : ENSAPEG00000013233
Gene Symbol: OPRK1
1 Cross references
196 Possible Orthologues:

Opioid Receptor, Delta 1b

Ensembl ID : ENSAPEG00000018674
Gene Symbol: OPRD1B
1 Cross references
178 Possible Orthologues:

Opioid Receptor, Kappa 1

Ensembl ID : ENSAPEG00000024484
Gene Symbol: OPRK1
1 Cross references
200 Possible Orthologues:

Opioid Receptor, Mu 1

Ensembl ID : ENSAPEG00000004468
Gene Symbol: OPRM1
1 Cross references
215 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSAPEG00000012071
Gene Symbol: OXTR
1 Cross references
186 Possible Orthologues:

Oxytocin Receptor A

Ensembl ID : ENSAPEG00000016873
Gene Symbol: OXTRA
1 Cross references
193 Possible Orthologues:

P21 Protein (Cdc42/rac)-Activated Kinase 4

Ensembl ID : ENSAPEG00000016955
Gene Symbol: PAK4
1 Cross references
163 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSAPEG00000001806
Gene Symbol: PTH1R
1 Cross references
198 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSAPEG00000004953
Gene Symbol: PPARG
2 Cross references
389 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha A

Ensembl ID : ENSAPEG00000014904
Gene Symbol: PPARAA
1 Cross references
384 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha B

Ensembl ID : ENSAPEG00000006919
Gene Symbol: PPARAB
1 Cross references
397 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Delta B

Ensembl ID : ENSAPEG00000019291
Gene Symbol: PPARDB
1 Cross references
392 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).